ConductScience.org, home

Paper30003189

p53 molecular approach to diagnosis and treatment of esophageal squamous cell carcinoma.

Shimada H. Ann Gastroenterol Surg, 2018. Cited by 42 papers, by iCite.

Cite this record

ConductScience Library. p53 molecular approach to diagnosis and treatment of esophageal squamous cell carcinoma. Papers, record 30003189. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30003189

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
p53 molecular approach to diagnosis and treatment of esophageal squamous cell carcinoma.
PubMed
Journal
Ann Gastroenterol Surg
PubMed
Year
2018
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
42
iCite
Relative citation ratio, by iCite
1.73
iCite
Revised in PubMed
2023-09-26
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shimada HHideakihttps://orcid.org/0000-0002-1990-8217

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128795280The use of neoadjuvant therapy for resectable locally advanced thoracic esophageal squamous cell carcinoma in an analysis of 5016 patients from 305 designated cancer care hospitals in Japan.Int J Clin Oncol2018https://conductscience.org/library/papers/28795280PubMed
224479409Selective intra-arterial infusion of rAd-p53 with chemotherapy for advanced oral cancer: a randomized clinical trial.BMC Med2014https://conductscience.org/library/papers/24479409PubMed
316734736Phase I/II adenoviral p53 gene therapy for chemoradiation resistant advanced esophageal squamous cell carcinoma.Cancer Sci2006https://conductscience.org/library/papers/16734736PubMed
430003189p53 molecular approach to diagnosis and treatment of esophageal squamous cell carcinoma.Ann Gastroenterol Surg2018https://conductscience.org/library/papers/30003189PubMed
512548611Titration of serum p53 antibodies in 1,085 patients with various types of malignant tumors: a multiinstitutional analysis by the Japan p53 Antibody Research Group.Cancer2003https://conductscience.org/library/papers/12548611PubMed
69649454Anti-p53 antibodies in patients with Barrett's esophagus or esophageal carcinoma can predate cancer diagnosis.Gastroenterology1998https://conductscience.org/library/papers/9649454PubMed
719052812Perioperative changes of serum p53 antibody titer is a predictor for survival in patients with esophageal squamous cell carcinoma.World J Surg2009https://conductscience.org/library/papers/19052812PubMed
810213922Detection of preoperative serum anti-p53 antibodies in gastric cancer.Tumour Biol1999https://conductscience.org/library/papers/10213922PubMed
927637603The Presence of Serum p53 Antibody Predicts the Pathological Tumor Response to Neoadjuvant Chemotherapy with Docetaxel, Cisplatin and Fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma.World J Surg2017https://conductscience.org/library/papers/27637603PubMed
1024241479Long-term monitoring of serum p53 antibody after neoadjuvant chemotherapy and surgery for esophageal adenocarcinoma: report of a case.Surg Today2014https://conductscience.org/library/papers/24241479PubMed
1128101684p53 Replacement Therapy for Cancer.Recent Results Cancer Res2016https://conductscience.org/library/papers/28101684PubMed
1223722592Randomized, controlled phase II study of post-surgery radiotherapy combined with recombinant adenoviral human p53 gene therapy in treatment of oral cancer.Cancer Gene Ther2013https://conductscience.org/library/papers/23722592PubMed
131394236p53 mutation and protein accumulation during multistage human esophageal carcinogenesis.Cancer Res1992https://conductscience.org/library/papers/1394236PubMed
1411495153Presence of serum p53 antibodies is associated with decreased in vitro chemosensitivity in patients with esophageal cancer.Surg Today2001https://conductscience.org/library/papers/11495153PubMed
1515289857Growth suppression of esophageal squamous cell carcinoma induced by heavy carbon-ion beams combined with p53 gene transfer.Int J Oncol2004https://conductscience.org/library/papers/15289857PubMed
1612563234Treatment response and prognosis of patients after recurrence of esophageal cancer.Surgery2003https://conductscience.org/library/papers/12563234PubMed
1711042560Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma.Cancer2000https://conductscience.org/library/papers/11042560PubMed
1822448886Prognostic significance of anti-p53 and anti-KRas circulating antibodies in esophageal cancer patients treated with chemoradiotherapy.BMC Cancer2012https://conductscience.org/library/papers/22448886PubMed
1928365443Genetic Alterations in Esophageal Tissues From Squamous Dysplasia to Carcinoma.Gastroenterology2017https://conductscience.org/library/papers/28365443PubMed
2026122021Germline and somatic genetic predictors of pathological response in neoadjuvant settings of rectal and esophageal cancers: systematic review and meta-analysis.Pharmacogenomics J2016https://conductscience.org/library/papers/26122021PubMed

See all 35 referencesDownload CSV of references

Cited by33

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.

PMIDTitleJournalYearIn PapersSource
42716804Impact of High Immunoreactivity on Surgically Treated Serum p53 Antibody-Positive Esophageal Squamous Cell Carcinoma after Neoadjuvant Therapy: A Multi-Institutional Study of 637 Cases.Ann Thorac Cardiovasc Surg2026https://conductscience.org/library/papers/42716804PubMed
42645687Epidemiological risk factors and inferred p53 pathway dysregulation in Esophageal squamous cell carcinoma in the Somali population.Discov Oncol2026https://conductscience.org/library/papers/42645687PubMed
41987866Prognostic and diagnostic significance of serum p53 antibody levels in patients with surgically treated pancreatic cancer.Oncol Lett2026https://conductscience.org/library/papers/41987866PubMed
41971943Computational Approach Improves Diagnostic Performance Based on Tumor-Associated Autoantibodies in Esophageal Squamous Cell Carcinoma.Comput Struct Biotechnol J2026https://conductscience.org/library/papers/41971943PubMed
41836060Mutant p53 and TP53 mutations in esophageal squamous cell carcinoma: consistency and diagnostic significance.Front Genet2026https://conductscience.org/library/papers/41836060PubMed
40747232Evaluating serum extra spindle pole bodies-like 1 protein vs p53 antibody for hepatitis B virus-related hepatocellular carcinoma diagnosis.World J Hepatol2025https://conductscience.org/library/papers/40747232PubMed
40607289Prognostic significance of six autoantibodies in esophageal squamous cell carcinoma: A prospective multi-institutional study.Ann Gastroenterol Surg2025https://conductscience.org/library/papers/40607289PubMed
38455491Serum NY-ESO-1 and p53 antibodies as useful tumor markers in gastric cancer.Ann Gastroenterol Surg2024https://conductscience.org/library/papers/38455491PubMed
38326601Serum NY-ESO-1 antibody as a predictive biomarker for postoperative recurrence of gastric cancer: a multicenter prospective observational study.Br J Cancer2024https://conductscience.org/library/papers/38326601PubMed
37693152Decoding SEC24 Homolog D, COPII coat complex component accuracy as a signature gene in three human cancers.Am J Cancer Res2023https://conductscience.org/library/papers/37693152PubMed
36619733Gastrointestinal and Pancratohepatobiliary Cancers: A Comprehensive Review on Epidemiology and Risk Factors Worldwide.Middle East J Dig Dis2022https://conductscience.org/library/papers/36619733PubMed
35832468Comparison between a new assay system, Elecsys® Anti-p53, and conventional MESACUP™ for the detection of serum anti-p53 antibodies: A multi-institutional study.Mol Clin Oncol2022https://conductscience.org/library/papers/35832468PubMed
35464847Identification and Validation of Chromobox Family Members as Potential Prognostic Biomarkers and Therapeutic Targets for Human Esophageal Cancer.Front Genet2022https://conductscience.org/library/papers/35464847PubMed
35430563Circular RNAs With Efficacy in Preclinical In Vitro and In Vivo Models of Esophageal Squamous Cell Carcinoma.Cancer Genomics Proteomics2022https://conductscience.org/library/papers/35430563PubMed
35251625Serum WT1-271 IgM antibody as a novel diagnostic marker for Gastric Cancer.Mol Clin Oncol2022https://conductscience.org/library/papers/35251625PubMed
34632560Presence of serum RalA and serum p53 autoantibodies in 1833 patients with various types of cancers.Int J Clin Oncol2022https://conductscience.org/library/papers/34632560PubMed
34504788Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer.Front Oncol2021https://conductscience.org/library/papers/34504788PubMed
34103026Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke.BMC Med2021https://conductscience.org/library/papers/34103026PubMed
33879806Urinary microRNA biomarkers for detecting the presence of esophageal cancer.Sci Rep2021https://conductscience.org/library/papers/33879806PubMed
33790647High Expression of MDM2 and the p53 Protein is Predictive Biomarkers for Poor Prognosis of Oesophageal Squamous Cell Carcinoma.Cancer Manag Res2021https://conductscience.org/library/papers/33790647PubMed

See all 33 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CEACAM31084PubTator's text mininghttps://conductscience.org/library/genes/1084NCBI Gene
CRP1401PubTator's text mininghttps://conductscience.org/library/genes/1401NCBI Gene
KRT193880PubTator's text mininghttps://conductscience.org/library/genes/3880NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30003189

GET https://conductscience.org/api/papers/v1/30003189/references?page=2